What can we learn from fMRI capture of visual hallucinations in Parkinson's disease?


Journal

Brain imaging and behavior
ISSN: 1931-7565
Titre abrégé: Brain Imaging Behav
Pays: United States
ID NLM: 101300405

Informations de publication

Date de publication:
Apr 2020
Historique:
pubmed: 25 8 2019
medline: 5 1 2021
entrez: 25 8 2019
Statut: ppublish

Résumé

With disease progression, patients with Parkinson's disease (PD) may have chronic visual hallucinations (VH). The mechanisms behind this invalidating non-motor symptom remain largely unknown, namely because it is extremely difficult to capture hallucination events. This study aimed to describe the patterns of brain functional changes when VH occur in PD patients. Nine PD patients were enrolled because of their frequent and chronic VH (> 10/day). Patients with severe cognitive decline (MMSE<18) were excluded. Patients were scanned during ON/OFF hallucinatory states and resting-state functional imaging (rs-fMRI) was performed. Data were analyzed in reference to the two-step method, which consists in: (i) a data-driven analysis of per-hallucinatory fMRI data, and (ii) selection of the components of interest based on a post-fMRI interview. The phenomenology of VH ranged from visual spots to distorting faces. First, at the individual level, several VH-related components of interest were identified and integrated in a second-level analysis. Using a random-effects self-organizing-group ICA, we evidenced increased connectivity in visual networks concomitant to VH, encompassing V2, V3 and the fusiform gyri bilaterally. Interestingly, the stability of the default-mode network (DMN) was found positively correlated with VH severity (Spearman's rho = 0.77, p = 0.05). By using a method that does not need online self-report, we showed that VH in PD patients were associated with functional changes in associative visual cortices, possibly linked with strengthened stability of resting-state networks.

Identifiants

pubmed: 31444780
doi: 10.1007/s11682-019-00185-6
pii: 10.1007/s11682-019-00185-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

329-335

Subventions

Organisme : Association France Parkinson
ID : None

Auteurs

Kathy Dujardin (K)

Inserm, U1171 - Degenerative & Vascular Cognitive Disorders, University of Lille, F-59000, Lille, France. kathy.dujardin@univ-lille.fr.
Neurology and Movement Disorders Department, CHU Lille, F-59000, Lille, France. kathy.dujardin@univ-lille.fr.

David Roman (D)

Psychiatry Department, CHU Lille, F-59000, Lille, France.

Guillaume Baille (G)

Inserm, U1171 - Degenerative & Vascular Cognitive Disorders, University of Lille, F-59000, Lille, France.
Neurology and Movement Disorders Department, CHU Lille, F-59000, Lille, France.

Delphine Pins (D)

CNRS, UMR 9193 - Cognitive and Affective Sciences - SCALab, University of Lille, F-59000, Lille, France.

Stéphanie Lefebvre (S)

CNRS, UMR 9193 - Cognitive and Affective Sciences - SCALab, University of Lille, F-59000, Lille, France.

Christine Delmaire (C)

Neuroimaging Department, CHU Lille, F-59000, Lille, France.

Luc Defebvre (L)

Inserm, U1171 - Degenerative & Vascular Cognitive Disorders, University of Lille, F-59000, Lille, France.
Neurology and Movement Disorders Department, CHU Lille, F-59000, Lille, France.

Renaud Jardri (R)

Psychiatry Department, CHU Lille, F-59000, Lille, France.
CNRS, UMR 9193 - Cognitive and Affective Sciences - SCALab, University of Lille, F-59000, Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH